My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

DexCom, Inc. - Common Stock (NQ:DXCM)

65.49 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

44 45 Next >

Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook

January 08, 2024

From DexCom, Inc.

Via Business Wire

HCA Healthcare Rallies: Weight-loss drugs really a big threat?

January 08, 2024

HCA Healthcare rebounds amid concerns about weight-loss drugs' impact. The healthcare giant's revenue growth hints at resilience despite sector challenges.

Via MarketBeat

Topics ETFs

Is NASDAQ:DXCM a Fit for Growth Investing Strategies? ↗

January 04, 2024

Should you consider DEXCOM INC (NASDAQ:DXCM) for growth investing?

Via Chartmill

The Latest Analyst Ratings For DexCom ↗

January 03, 2024

Via Benzinga

DexCom Unusual Options Activity ↗

January 02, 2024

Via Benzinga

Looking Into DexCom's Recent Short Interest ↗

December 22, 2023

Via Benzinga

$100 Invested In This Stock 15 Years Ago Would Be Worth $21,000 Today ↗

December 21, 2023

Via Benzinga

DexCom's Options Frenzy: What You Need to Know ↗

December 20, 2023

Via Benzinga

Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

January 03, 2024

Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase.

Via Chartmill

1 Stock-Split Stock to Buy Hand Over Fist in 2024 and 1 to Avoid ↗

January 03, 2024

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer that's ripe for the picking, as well as an...

Via The Motley Fool

For those who appreciate growth without the sticker shock, NASDAQ:DXCM is worth considering. ↗

January 02, 2024

NASDAQ:DXCM stands out as a growth opportunity that won't break the bank.

Via Chartmill

These 3 Companies Can Be the Next Stock-Split Stocks in 2024 ↗

December 29, 2023

Since mid-2021, Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk have conducted stock splits. Three well-known companies look set to follow in...

Via The Motley Fool

DEXCOM INC (NASDAQ:DXCM) showing high EPS and FCF growth while beating expectations ↗

December 13, 2023

DEXCOM INC (NASDAQ:DXCM) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

Is NASDAQ:DXCM on the Verge of a Major Breakout as a Strong Growth Stock? ↗

December 12, 2023

DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.

Via Chartmill

NASDAQ:DXCM is showing decent growth, but is still valued reasonably. ↗

December 11, 2023

NASDAQ:DXCM is not too expensive for the growth it is showing.

Via Chartmill

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,800 Today ↗

December 07, 2023

Via Benzinga

Meet the Stock-Split Stock Warren Buffett Is Likeliest to Buy in 2024 ↗

December 27, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a stock-split stock that checks all the right boxes for the Oracle of Omaha.

Via The Motley Fool

3 Stock-Split Stocks Billionaires Are Piling Into Ahead of 2024 ↗

December 25, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry leaders Wall Street's brightest money managers want to own for...

Via The Motley Fool

Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference

December 19, 2023

From DexCom, Inc.

Via Business Wire

3 Stock-Split Stocks With 51% to 128% Upside in 2024, According to Select Wall Street Analysts ↗

December 18, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three high-flying stocks a trio of Wall Street analysts believe can soar in the...

Via The Motley Fool

(DXCM) - Analyzing DexCom's Short Interest ↗

December 06, 2023

Via Benzinga

Market Whales and Their Recent Bets on DXCM Options ↗

December 05, 2023

Via Benzinga

Pet Parents Keep Spending ↗

December 13, 2023

We also talk with Dexcom CEO Kevin Sayer about the impact of weight loss drugs on diabetes care.

Via The Motley Fool

Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump

December 06, 2023

From DexCom, Inc.

Via Business Wire

DexCom Stock Earns Healthy Relative Strength Rating Upgrade ↗

December 05, 2023

In a welcome move, medical device maker DexCom stock saw its Relative Strength Rating rise from 70 to 77 on Tuesday.

Via Investor's Business Daily

Analyst Expectations for DexCom's Future ↗

December 04, 2023

Via Benzinga

Is NASDAQ:DXCM a Fit for Growth Investing Strategies? ↗

November 22, 2023

Is DEXCOM INC (NASDAQ:DXCM) suited for growth investing?

Via Chartmill

1 Stock-Split Stock to Buy Hand Over Fist in December, and 1 to Avoid Like the Plague ↗

December 04, 2023

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer, as well as an industry leader that could...

Via The Motley Fool

Investing $5,000 in These 3 Stocks Could Make You Rich ↗

November 27, 2023

Artificial intelligence should be a huge tailwind for all three of these stocks.

Via The Motley Fool

Topics Artificial Intelligence

Dexcom Announces Upcoming Conference Presentation

November 21, 2023

From DexCom, Inc.

Via Business Wire

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

44 45 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.